Johnson & Johnson at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2020 / 02:40PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It's my pleasure to host this session with Johnson & Johnson. With us, we have Mathai Mammen, who is the Global Head of R&D for the Pharmaceuticals business. In terms of format, it's going to be a fireside chat for 30 minutes. We're going to try to do a polling question here. Worked well this morning, so we're going to do another one.

So Mathai, welcome, and thanks so much for joining us virtually this morning. Can you hear me okay?

Mathai Mammen - Johnson & Johnson - Global Head of Research & Development of Janssen Pharmaceutical

I can, Larry. Thanks for having me. It's a pleasure.

Questions and Answers:

Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Great. Mathai, I thought we'd start with a big
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot